Katherine Elena Economy, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pregnancy Complications, Cardiovascular | 17 | 2024 | 513 | 3.020 |
Why?
|
Delivery, Obstetric | 6 | 2020 | 941 | 1.260 |
Why?
|
Heart Diseases | 4 | 2021 | 2795 | 0.760 |
Why?
|
Pregnancy Complications, Hematologic | 3 | 2020 | 180 | 0.600 |
Why?
|
Pregnancy | 45 | 2024 | 29893 | 0.580 |
Why?
|
Hematologic Agents | 2 | 2019 | 40 | 0.530 |
Why?
|
Heart Valve Prosthesis | 4 | 2018 | 1463 | 0.500 |
Why?
|
Cesarean Section | 3 | 2020 | 1399 | 0.460 |
Why?
|
Pregnancy Outcome | 8 | 2021 | 2923 | 0.390 |
Why?
|
Pre-Eclampsia | 4 | 2024 | 1233 | 0.370 |
Why?
|
Tetralogy of Fallot | 4 | 2024 | 618 | 0.360 |
Why?
|
Abortion, Induced | 2 | 2024 | 462 | 0.300 |
Why?
|
Labor, Obstetric | 1 | 2011 | 323 | 0.290 |
Why?
|
Thrombophilia | 2 | 2020 | 306 | 0.250 |
Why?
|
Gestational Age | 5 | 2020 | 3580 | 0.240 |
Why?
|
Pulmonary Embolism | 1 | 2018 | 2571 | 0.240 |
Why?
|
Pregnancy Complications | 6 | 2018 | 2949 | 0.240 |
Why?
|
American Heart Association | 2 | 2020 | 1043 | 0.230 |
Why?
|
Cardiology | 1 | 2015 | 1693 | 0.230 |
Why?
|
Pregnancy Complications, Neoplastic | 3 | 2016 | 258 | 0.220 |
Why?
|
Monitoring, Physiologic | 1 | 2011 | 1780 | 0.220 |
Why?
|
Anti-Arrhythmia Agents | 2 | 2020 | 774 | 0.210 |
Why?
|
Heart Defects, Congenital | 5 | 2022 | 4673 | 0.210 |
Why?
|
Societies, Medical | 1 | 2015 | 3923 | 0.210 |
Why?
|
Postnatal Care | 3 | 2020 | 260 | 0.200 |
Why?
|
Pericarditis | 1 | 2023 | 136 | 0.200 |
Why?
|
Tocolytic Agents | 1 | 2001 | 24 | 0.190 |
Why?
|
Prenatal Care | 4 | 2023 | 1141 | 0.190 |
Why?
|
Female | 49 | 2024 | 392544 | 0.190 |
Why?
|
Vascular Resistance | 1 | 2024 | 933 | 0.180 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2024 | 558 | 0.180 |
Why?
|
Breast Neoplasms | 4 | 2022 | 20982 | 0.170 |
Why?
|
Heart Rate, Fetal | 1 | 2020 | 75 | 0.170 |
Why?
|
Extraction, Obstetrical | 1 | 2019 | 27 | 0.170 |
Why?
|
Connective Tissue Diseases | 2 | 2019 | 285 | 0.160 |
Why?
|
Infant, Newborn | 9 | 2022 | 26199 | 0.160 |
Why?
|
Valsalva Maneuver | 1 | 2019 | 99 | 0.160 |
Why?
|
Registries | 1 | 2015 | 8247 | 0.160 |
Why?
|
Fibrinolytic Agents | 2 | 2020 | 2075 | 0.160 |
Why?
|
Magnetic Resonance Imaging, Cine | 2 | 2024 | 1061 | 0.160 |
Why?
|
Amenorrhea | 1 | 2002 | 483 | 0.150 |
Why?
|
Fetal Heart | 1 | 2020 | 281 | 0.150 |
Why?
|
Calcium Channel Blockers | 1 | 2001 | 691 | 0.150 |
Why?
|
Arrhythmias, Cardiac | 3 | 2019 | 2247 | 0.150 |
Why?
|
Blood Pressure | 1 | 2013 | 8479 | 0.150 |
Why?
|
Coronary Circulation | 1 | 2024 | 1611 | 0.150 |
Why?
|
Infant, Small for Gestational Age | 1 | 2020 | 463 | 0.150 |
Why?
|
Prospective Studies | 6 | 2023 | 54435 | 0.150 |
Why?
|
Heart Ventricles | 3 | 2024 | 3813 | 0.140 |
Why?
|
Maternal-Fetal Exchange | 2 | 2020 | 461 | 0.140 |
Why?
|
Pheochromocytoma | 2 | 2009 | 328 | 0.140 |
Why?
|
Breast Feeding | 2 | 2023 | 1356 | 0.140 |
Why?
|
Tachycardia, Supraventricular | 1 | 2020 | 273 | 0.140 |
Why?
|
Cardiovascular Diseases | 1 | 2023 | 15520 | 0.140 |
Why?
|
Anesthetics | 1 | 2022 | 523 | 0.140 |
Why?
|
Risk Adjustment | 1 | 2020 | 601 | 0.140 |
Why?
|
Pelvic Pain | 1 | 1999 | 298 | 0.140 |
Why?
|
Vagina | 1 | 2002 | 841 | 0.130 |
Why?
|
Cardiovascular System | 1 | 2024 | 836 | 0.130 |
Why?
|
Hemorrhage | 2 | 2020 | 3422 | 0.130 |
Why?
|
Preservatives, Pharmaceutical | 1 | 2015 | 34 | 0.130 |
Why?
|
Humans | 49 | 2024 | 761208 | 0.130 |
Why?
|
Cardiovascular Agents | 2 | 2019 | 842 | 0.130 |
Why?
|
Postpartum Hemorrhage | 1 | 2019 | 272 | 0.130 |
Why?
|
Pulmonary Edema | 4 | 2014 | 408 | 0.120 |
Why?
|
Ventricular Function, Right | 2 | 2024 | 618 | 0.120 |
Why?
|
Coronary Vessel Anomalies | 1 | 2018 | 307 | 0.120 |
Why?
|
Fetal Diseases | 1 | 2020 | 912 | 0.120 |
Why?
|
Abruptio Placentae | 1 | 2015 | 118 | 0.120 |
Why?
|
Fontan Procedure | 1 | 2020 | 796 | 0.120 |
Why?
|
Adrenal Gland Neoplasms | 2 | 2009 | 732 | 0.110 |
Why?
|
Bioprosthesis | 1 | 2018 | 591 | 0.110 |
Why?
|
Uterus | 2 | 2012 | 651 | 0.110 |
Why?
|
Antiphospholipid Syndrome | 1 | 2015 | 165 | 0.110 |
Why?
|
Stroke Volume | 3 | 2024 | 5521 | 0.110 |
Why?
|
Clinical Protocols | 1 | 2019 | 1436 | 0.110 |
Why?
|
Hypertension | 1 | 2013 | 8536 | 0.110 |
Why?
|
Metanephrine | 2 | 2009 | 25 | 0.110 |
Why?
|
Rheumatic Heart Disease | 1 | 2014 | 163 | 0.110 |
Why?
|
Cardiomyopathies | 2 | 2019 | 2021 | 0.110 |
Why?
|
Laparoscopy | 2 | 2002 | 2035 | 0.100 |
Why?
|
Mitral Valve Stenosis | 1 | 2014 | 341 | 0.100 |
Why?
|
Birth Weight | 1 | 2020 | 2104 | 0.100 |
Why?
|
Retrospective Studies | 10 | 2024 | 80674 | 0.100 |
Why?
|
Fetus | 2 | 2016 | 1864 | 0.100 |
Why?
|
Heart Valve Diseases | 1 | 2019 | 1031 | 0.100 |
Why?
|
Fetal Growth Retardation | 1 | 2015 | 580 | 0.100 |
Why?
|
Electric Countershock | 1 | 2014 | 533 | 0.090 |
Why?
|
Anesthesia | 1 | 2022 | 1591 | 0.090 |
Why?
|
Placenta | 1 | 2020 | 1711 | 0.090 |
Why?
|
Adult | 24 | 2024 | 221119 | 0.090 |
Why?
|
Coronary Artery Disease | 2 | 2021 | 6505 | 0.090 |
Why?
|
Anticoagulants | 2 | 2016 | 4795 | 0.090 |
Why?
|
Hernia, Diaphragmatic | 1 | 2011 | 244 | 0.090 |
Why?
|
Thromboembolism | 1 | 2016 | 992 | 0.090 |
Why?
|
Premature Birth | 1 | 2022 | 1784 | 0.090 |
Why?
|
Heart Block | 1 | 2011 | 385 | 0.080 |
Why?
|
Pilot Projects | 1 | 2023 | 8642 | 0.080 |
Why?
|
Ultrasonography, Prenatal | 5 | 2020 | 1757 | 0.080 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2014 | 732 | 0.080 |
Why?
|
Pregnancy, High-Risk | 1 | 2010 | 121 | 0.080 |
Why?
|
Genital Neoplasms, Female | 1 | 1995 | 533 | 0.080 |
Why?
|
Vascular Diseases | 1 | 2018 | 1160 | 0.080 |
Why?
|
Patient Compliance | 1 | 2019 | 2688 | 0.080 |
Why?
|
Aortic Coarctation | 1 | 2011 | 275 | 0.080 |
Why?
|
Aortic Valve | 1 | 2018 | 1959 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2507 | 0.080 |
Why?
|
Twins, Monozygotic | 1 | 2010 | 470 | 0.080 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2018 | 1555 | 0.070 |
Why?
|
Mastectomy | 1 | 2016 | 1818 | 0.070 |
Why?
|
Fetal Death | 3 | 2020 | 435 | 0.070 |
Why?
|
Lymph Node Excision | 1 | 2014 | 1270 | 0.070 |
Why?
|
Ventricular Function, Left | 1 | 2020 | 3899 | 0.070 |
Why?
|
Transposition of Great Vessels | 1 | 2011 | 580 | 0.070 |
Why?
|
Puerperal Disorders | 1 | 2009 | 301 | 0.070 |
Why?
|
Thrombosis | 1 | 2020 | 2944 | 0.070 |
Why?
|
Electrodes, Implanted | 1 | 2011 | 839 | 0.070 |
Why?
|
Exercise | 1 | 2023 | 5874 | 0.070 |
Why?
|
Mammaplasty | 1 | 2016 | 1232 | 0.070 |
Why?
|
Aortic Valve Stenosis | 1 | 2018 | 2018 | 0.060 |
Why?
|
Risk Factors | 9 | 2020 | 74239 | 0.060 |
Why?
|
Pacemaker, Artificial | 1 | 2011 | 807 | 0.060 |
Why?
|
Obstetric Labor, Premature | 2 | 2010 | 272 | 0.060 |
Why?
|
Ventricular Remodeling | 1 | 2013 | 1270 | 0.060 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2011 | 518 | 0.060 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2015 | 2746 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2015 | 10756 | 0.050 |
Why?
|
Ultrasonography | 2 | 2014 | 5969 | 0.050 |
Why?
|
Infant | 2 | 2023 | 36169 | 0.050 |
Why?
|
Colchicine | 1 | 2023 | 258 | 0.050 |
Why?
|
Postpartum Period | 2 | 2024 | 1178 | 0.050 |
Why?
|
MEDLINE | 1 | 2001 | 119 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 3 | 2012 | 36415 | 0.050 |
Why?
|
Infant Mortality | 2 | 2023 | 752 | 0.050 |
Why?
|
Nifedipine | 1 | 2001 | 220 | 0.050 |
Why?
|
Pregnancy, Prolonged | 1 | 2000 | 9 | 0.050 |
Why?
|
Catheter Ablation | 1 | 2014 | 2751 | 0.050 |
Why?
|
Leiomyoma | 1 | 2006 | 636 | 0.050 |
Why?
|
Uterine Contraction | 1 | 2001 | 91 | 0.050 |
Why?
|
Comorbidity | 1 | 2015 | 10516 | 0.050 |
Why?
|
Echocardiography | 3 | 2020 | 5006 | 0.040 |
Why?
|
Cardiac Surgical Procedures | 3 | 2024 | 3627 | 0.040 |
Why?
|
Fractional Flow Reserve, Myocardial | 1 | 2024 | 345 | 0.040 |
Why?
|
Tachycardia | 2 | 2014 | 599 | 0.040 |
Why?
|
Microvessels | 1 | 2024 | 580 | 0.040 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2022 | 629 | 0.040 |
Why?
|
Labor, Induced | 1 | 2000 | 152 | 0.040 |
Why?
|
Microcirculation | 1 | 2024 | 1280 | 0.040 |
Why?
|
Pulmonary Valve Insufficiency | 1 | 2020 | 140 | 0.040 |
Why?
|
Pelvic Inflammatory Disease | 1 | 1999 | 96 | 0.040 |
Why?
|
Taxoids | 1 | 2022 | 668 | 0.040 |
Why?
|
Heart Failure | 2 | 2021 | 11701 | 0.040 |
Why?
|
Treatment Outcome | 7 | 2023 | 64681 | 0.040 |
Why?
|
Teratogens | 1 | 2019 | 117 | 0.040 |
Why?
|
Chemoprevention | 1 | 2020 | 325 | 0.040 |
Why?
|
Periodicity | 1 | 1999 | 347 | 0.040 |
Why?
|
Electrocardiography | 3 | 2020 | 6387 | 0.040 |
Why?
|
Young Adult | 7 | 2024 | 59221 | 0.040 |
Why?
|
Pregnancy Trimester, Third | 2 | 2009 | 583 | 0.030 |
Why?
|
Uterine Neoplasms | 1 | 2006 | 1420 | 0.030 |
Why?
|
Cervix Uteri | 1 | 2000 | 570 | 0.030 |
Why?
|
Radiography | 3 | 2014 | 6974 | 0.030 |
Why?
|
Medical Records | 1 | 2002 | 1409 | 0.030 |
Why?
|
Standard of Care | 1 | 2019 | 550 | 0.030 |
Why?
|
Cardiac Imaging Techniques | 1 | 2018 | 278 | 0.030 |
Why?
|
Cohort Studies | 4 | 2016 | 41496 | 0.030 |
Why?
|
Alkalosis, Respiratory | 1 | 2014 | 20 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2024 | 39126 | 0.030 |
Why?
|
Drug Monitoring | 1 | 2020 | 961 | 0.030 |
Why?
|
International Cooperation | 1 | 2020 | 1423 | 0.030 |
Why?
|
Regression Analysis | 1 | 2023 | 6345 | 0.030 |
Why?
|
Methylene Blue | 1 | 2014 | 155 | 0.030 |
Why?
|
Risk Assessment | 4 | 2020 | 24021 | 0.030 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2023 | 2270 | 0.030 |
Why?
|
Coronary Vessels | 1 | 2024 | 3111 | 0.030 |
Why?
|
Breast Implants | 1 | 2016 | 407 | 0.030 |
Why?
|
Cardiac Volume | 1 | 2013 | 197 | 0.020 |
Why?
|
Adolescent | 5 | 2020 | 88298 | 0.020 |
Why?
|
Dyspnea | 2 | 2009 | 1347 | 0.020 |
Why?
|
Aspirin | 1 | 2023 | 3129 | 0.020 |
Why?
|
Coloring Agents | 1 | 2014 | 561 | 0.020 |
Why?
|
Prosthesis Design | 1 | 2018 | 2114 | 0.020 |
Why?
|
Recurrence | 1 | 2023 | 8457 | 0.020 |
Why?
|
Endometriosis | 1 | 1999 | 870 | 0.020 |
Why?
|
Menotropins | 1 | 1990 | 41 | 0.020 |
Why?
|
Medicaid | 1 | 2023 | 2813 | 0.020 |
Why?
|
Perinatal Mortality | 1 | 2010 | 101 | 0.020 |
Why?
|
Sensitivity and Specificity | 2 | 2002 | 14675 | 0.020 |
Why?
|
Thoracotomy | 1 | 2011 | 366 | 0.020 |
Why?
|
Adrenergic alpha-Antagonists | 1 | 2009 | 174 | 0.020 |
Why?
|
Fetofetal Transfusion | 1 | 2010 | 113 | 0.020 |
Why?
|
Catecholamines | 1 | 2009 | 387 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 2018 | 2193 | 0.020 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2009 | 2131 | 0.020 |
Why?
|
Acute Disease | 1 | 1999 | 7226 | 0.020 |
Why?
|
United States | 3 | 2023 | 72339 | 0.020 |
Why?
|
Hemodynamics | 1 | 2019 | 4165 | 0.020 |
Why?
|
Diseases in Twins | 1 | 2010 | 446 | 0.020 |
Why?
|
Recovery of Function | 1 | 2018 | 2981 | 0.020 |
Why?
|
Consensus | 1 | 2018 | 3134 | 0.020 |
Why?
|
Follicle Stimulating Hormone | 1 | 1990 | 726 | 0.020 |
Why?
|
Hypertension, Pulmonary | 1 | 2019 | 1592 | 0.020 |
Why?
|
Male | 3 | 2020 | 360693 | 0.020 |
Why?
|
Luteinizing Hormone | 1 | 1990 | 820 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 6585 | 0.020 |
Why?
|
Anesthesia, Obstetrical | 1 | 2010 | 232 | 0.020 |
Why?
|
Maternal Mortality | 1 | 2010 | 301 | 0.020 |
Why?
|
Maternal Age | 1 | 2010 | 809 | 0.020 |
Why?
|
Stillbirth | 1 | 2010 | 369 | 0.020 |
Why?
|
Parity | 1 | 2010 | 929 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2014 | 12976 | 0.020 |
Why?
|
Pericardium | 1 | 2011 | 674 | 0.020 |
Why?
|
Smoking | 1 | 2023 | 9055 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2024 | 15841 | 0.020 |
Why?
|
Ovary | 1 | 1990 | 957 | 0.020 |
Why?
|
Endometrial Neoplasms | 1 | 1995 | 1366 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2001 | 10218 | 0.010 |
Why?
|
Safety Management | 1 | 2010 | 761 | 0.010 |
Why?
|
Chronic Disease | 1 | 1999 | 9319 | 0.010 |
Why?
|
Infertility, Female | 1 | 1990 | 761 | 0.010 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3245 | 0.010 |
Why?
|
Hemoglobins | 1 | 2009 | 1525 | 0.010 |
Why?
|
Lung | 2 | 2014 | 9979 | 0.010 |
Why?
|
Prognosis | 2 | 2014 | 29687 | 0.010 |
Why?
|
Uterine Cervical Neoplasms | 1 | 1995 | 2019 | 0.010 |
Why?
|
Diagnostic Errors | 1 | 2009 | 1265 | 0.010 |
Why?
|
Headache | 1 | 2009 | 1255 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15308 | 0.010 |
Why?
|
Autoantibodies | 1 | 1990 | 2119 | 0.010 |
Why?
|
Prevalence | 1 | 2018 | 15721 | 0.010 |
Why?
|
Abortion, Spontaneous | 1 | 2006 | 533 | 0.010 |
Why?
|
Administration, Intravaginal | 1 | 2000 | 149 | 0.010 |
Why?
|
Pregnancy, Multiple | 1 | 2000 | 215 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11119 | 0.010 |
Why?
|
Algorithms | 1 | 2019 | 14025 | 0.010 |
Why?
|
Time Factors | 1 | 2020 | 39957 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 1995 | 4872 | 0.010 |
Why?
|
Length of Stay | 1 | 2011 | 6417 | 0.010 |
Why?
|
Endosonography | 1 | 2000 | 608 | 0.010 |
Why?
|
Neoplasms | 1 | 2024 | 22140 | 0.010 |
Why?
|
Middle Aged | 4 | 2018 | 220853 | 0.010 |
Why?
|
Water | 1 | 2000 | 1410 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2016 | 15637 | 0.010 |
Why?
|
Incidence | 1 | 2010 | 21365 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2006 | 8003 | 0.010 |
Why?
|
Animals | 1 | 2001 | 168079 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2000 | 7400 | 0.000 |
Why?
|
Estradiol | 1 | 1990 | 1937 | 0.000 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1990 | 3803 | 0.000 |
Why?
|
Fertilization in Vitro | 1 | 1990 | 1292 | 0.000 |
Why?
|
Child | 1 | 2006 | 80152 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1990 | 11067 | 0.000 |
Why?
|